These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 7121935
1. Fracture frequency and bone preservation in postmenopausal women treated with estrogen. Jensen GF, Christiansen C, Transbøl I. Obstet Gynecol; 1982 Oct; 60(4):493-6. PubMed ID: 7121935 [Abstract] [Full Text] [Related]
5. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study. Bagger YZ, Tankó LB, Alexandersen P, Hansen HB, Møllgaard A, Ravn P, Qvist P, Kanis JA, Christiansen C. Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905 [Abstract] [Full Text] [Related]
8. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates. Confavreux CB, Fontana A, Guastalla JP, Munoz F, Brun J, Delmas PD. Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847 [Abstract] [Full Text] [Related]
9. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. Richelson LS, Wahner HW, Melton LJ, Riggs BL. N Engl J Med; 1984 Nov 15; 311(20):1273-5. PubMed ID: 6493283 [Abstract] [Full Text] [Related]
10. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study. Barrett-Connor E, Wehren LE, Siris ES, Miller P, Chen YT, Abbott TA, Berger ML, Santora AC, Sherwood LM. Menopause; 2003 Nov 15; 10(5):412-9. PubMed ID: 14501602 [Abstract] [Full Text] [Related]
11. Determinants of bone mass in postmenopausal women. Aloia JF, Vaswani AN, Yeh JK, Ross P, Ellis K, Cohn SH. Arch Intern Med; 1983 Sep 15; 143(9):1700-4. PubMed ID: 6615091 [Abstract] [Full Text] [Related]
12. Association of grip strength change with menopausal bone loss and related fractures: a population-based follow-up study. Sirola J, Rikkonen T, Tuppurainen M, Jurvelin JS, Kröger H. Calcif Tissue Int; 2006 Apr 15; 78(4):218-26. PubMed ID: 16604281 [Abstract] [Full Text] [Related]
13. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study. Yoshimura N, Kasamatsu T, Sakata K, Hashimoto T, Cooper C. J Bone Miner Metab; 2002 Apr 15; 20(5):303-10. PubMed ID: 12203037 [Abstract] [Full Text] [Related]
14. Menopausal changes in bone remodeling. Heaney RP, Recker RR, Saville PD. J Lab Clin Med; 1978 Dec 15; 92(6):964-70. PubMed ID: 739174 [Abstract] [Full Text] [Related]
15. Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years. Love RR, Barden HS, Mazess RB, Epstein S, Chappell RJ. Arch Intern Med; 1994 Nov 28; 154(22):2585-8. PubMed ID: 7979855 [Abstract] [Full Text] [Related]
20. Identification of the risk factors for osteoporosis among postmenopausal women. Demir B, Haberal A, Geyik P, Baskan B, Ozturkoglu E, Karacay O, Deveci S. Maturitas; 2008 Nov 28; 60(3-4):253-6. PubMed ID: 18778903 [Abstract] [Full Text] [Related] Page: [Next] [New Search]